Literature DB >> 11154732

Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism.

V Vasiliou1, A Pappa, D R Petersen.   

Abstract

Aldehydes are highly reactive molecules that are intermediates or products involved in a broad spectrum of physiologic, biologic and pharmacologic processes. Aldehydes are generated from chemically diverse endogenous and exogenous precursors and aldehyde-mediated effects vary from homeostatic and therapeutic to cytotoxic, and genotoxic. One of the most important pathways for aldehyde metabolism is their oxidation to carboxylic acids by aldehyde dehydrogenases (ALDHs). Oxidation of the carbonyl functional group is considered a general detoxification process in that polymorphisms of several human ALDHs are associated a disease phenotypes or pathophysiologies. However, a number of ALDH-mediated oxidation form products that are known to possess significant biologic, therapeutic and/or toxic activities. These include the retinoic acid, an important element for vertebrate development, gamma-aminobutyric acid (GABA), an important neurotransmitter, and trichloroacetic acid, a potential toxicant. This review summarizes the ALDHs with an emphasis on catalytic properties and xenobiotic substrates of these enzymes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154732     DOI: 10.1016/s0009-2797(00)00211-8

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  110 in total

1.  The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.

Authors:  Jan S Moreb; Deniz Ucar; Shuhong Han; John K Amory; Alex S Goldstein; Blanca Ostmark; Lung-Ji Chang
Journal:  Chem Biol Interact       Date:  2011-11-03       Impact factor: 5.192

2.  Molecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal.

Authors:  William Black; Ying Chen; Akiko Matsumoto; David C Thompson; Natalie Lassen; Aglaia Pappa; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2012-03-08       Impact factor: 7.376

3.  Selection of tumorigenic melanoma cells using ALDH.

Authors:  Jim B Boonyaratanakornkit; Lili Yue; Lauren R Strachan; Kenneth J Scalapino; Philip E LeBoit; Ying Lu; Stanley P Leong; Janellen E Smith; Ruby Ghadially
Journal:  J Invest Dermatol       Date:  2010-08-26       Impact factor: 8.551

4.  Neo-epitopes on crotonaldehyde modified DNA preferably recognize circulating autoantibodies in cancer patients.

Authors:  Badar Ul Islam; Parvez Ahmad; Gulam Rabbani; Kiran Dixit; Shahid Ali Siddiqui; Asif Ali
Journal:  Tumour Biol       Date:  2015-08-29

5.  Geraniol and geranial dehydrogenases induced in anaerobic monoterpene degradation by Castellaniella defragrans.

Authors:  Frauke Lüddeke; Annika Wülfing; Markus Timke; Frauke Germer; Johanna Weber; Aytac Dikfidan; Tobias Rahnfeld; Dietmar Linder; Anke Meyerdierks; Jens Harder
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

6.  Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.

Authors:  Vishal R Mali; Ruizhuo Ning; Jieli Chen; Xiao-Ping Yang; Jiang Xu; Suresh S Palaniyandi
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-20

7.  Aldehyde dehydrogenase activity as a functional marker for lung cancer.

Authors:  Deniz Ucar; Christopher R Cogle; James R Zucali; Blanca Ostmark; Edward W Scott; Robert Zori; Brian A Gray; Jan S Moreb
Journal:  Chem Biol Interact       Date:  2008-10-05       Impact factor: 5.192

Review 8.  Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

Authors:  Grant R Budas; Marie-Hélène Disatnik; Daria Mochly-Rosen
Journal:  Trends Cardiovasc Med       Date:  2009-07       Impact factor: 6.677

9.  Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPbeta interaction.

Authors:  Guillermo Elizondo; Irma M Medina-Díaz; Raymundo Cruz; Frank J Gonzalez; Libia Vega
Journal:  Biochem Pharmacol       Date:  2008-10-17       Impact factor: 5.858

Review 10.  Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.

Authors:  Navin Pinto; Susan M Ludeman; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.